Disease-modifying therapy prescription patterns in people with multiple sclerosis by age.

Yinan ZhangAmber SalterShan JinWilliam J CulpepperGary R CutterMitchell WallinOlaf Stüve

Published in: Therapeutic advances in neurological disorders (2021)

These findings suggest that DMTs are under-utilized in the younger population and continue to be commonly prescribed in the elderly. Broader access may explain the higher prescription rate of DMTs in US veterans.

Keyphrases

multiple sclerosis
middle aged
community dwelling
stem cells
mesenchymal stem cells
bone marrow
cell therapy
smoking cessation
chemotherapy induced